SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-17-000105
Filing Date
2017-11-02
Accepted
2017-11-02 16:06:37
Documents
20
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201711028xkdoc.htm 8-K 34699
2 PRESS RELEASE pdli-201711028xkex991.htm EX-99.1 256353
3 PRESENTATION pdli-201711028xkex992.htm EX-99.2 7223
4 INFORMATION SHEET pdli-201711028xkex993.htm EX-99.3 234626
5 pdllogoeaa02.jpg GRAPHIC 21306
6 slide1a52.jpg GRAPHIC 47341
7 slide2a52.jpg GRAPHIC 221884
8 slide3a52.jpg GRAPHIC 136137
9 slide4a52.jpg GRAPHIC 101314
10 slide5a52.jpg GRAPHIC 115890
11 slide6a52.jpg GRAPHIC 182326
12 slide7a52.jpg GRAPHIC 131620
13 slide8a50.jpg GRAPHIC 114626
14 slide9a49.jpg GRAPHIC 29172
15 slidn33.jpg GRAPHIC 154992
16 slidn34.jpg GRAPHIC 101807
17 slidn35.jpg GRAPHIC 144317
18 slidn36.jpg GRAPHIC 175049
19 slidn37.jpg GRAPHIC 105652
20 slidn38.jpg GRAPHIC 33678
  Complete submission text file 0000882104-17-000105.txt   3037981
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 171172289
SIC: 2836 Biological Products, (No Diagnostic Substances)